When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the ...

The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound ... And investors weren't thrilled with the numbers, leading to a 7% drop in the share price that day. Results for the fourth ...

Time for your weekly edition of the Defector Funbag. Got something on your mind? Email the Funbag. And buy Drew’s book, The ...

“we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space,” he said. Pfizer revealed in December that it had decided to drop the twice-daily ...

Research shows that GLP-1 receptor agonists like Ozempic can help you drop weight, manage diabetes, and even potentially ...

An anxious generation turns to functional foods and beverages and alternative medicine, inspiring better-for-you innovation.

In one research, over four months participants on the Allurion Program showed a 14% drop in overall weight and a 5.6% gain in lean body mass. Another trial revealed a 15.7% weight decrease devoid of ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...

Oprah Winfrey is sparking a debate around weight, willpower and perception after the media mogul revealed her perceptions ...

The readout comes on the heels of CagriSema’s disappointing Phase III performance, where it missed Novo’s projection of 25% ...